To identify a potential novel target within metabolic proteins that could reduce ERα stability and cell proliferation in BC cells, we reasoned that such protein should be lethal for tumor cells while its inhibition must not significantly affect the proliferation of non-transformed cells. The gene discussed is ESR1; the disease is neoplasm.